Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
Not yet recruiting · NCT07328529 · Registry updated 2026-01-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Sex Chromosome Disorders, Signs and Symptoms, X-linked disease, chromosomal disorder, fragile X syndrome, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder | Not yet recruiting | Phase 2 | 2026-01-09 | NCT07328529 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Azevan Pharmaceuticals | 1 |
| Congressionally Directed Medical Research Programs | 87 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital | Cincinnati | United States | 66 |
| Rush University Medical Center | Chicago | United States | 283 |
| University of California, Davis, MIND Institute | Sacramento | United States | 1 |